Second Opinion: Ophthalmic Advances

In this Second Opinion segment, Ehsan Sadri, MD, and William Trattler, MD, share a lively discussion on the advancements that continue to emerge in eye care amid a pandemic. They touch upon the uptick in patient volume and the developing or available treatments for unmet needs, including pharmacologic therapy for presbyopia. Recent innovations from manufacturers are also enhancing the workflow and experience for cataract and refractive surgeons and their patients.